PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2007 | 2 | 174-180
Article title

Enantioselective bioreduction of propentofylline using yeast in water and organic solvents

Title variants
Languages of publication
EN
Abstracts
EN
Propentofylline (PPT) is a drug used in the treatment of both vascular dementia and Alzheimer type dementia. Hydroxy-metabolites of propentofylline (OHPPT) also demonstrate the same biological activity as the parent compound. As steroisomers of HOPPT are not commercially available, we had to produce them for pharmacological and pharmacokinetic studies. The aim of this study was to find the strains of Saccharomyces cerevisiae yielding enantiomerically pure (R)- or (S)-1-(5-hydroxyhexyl)-3,5-dimethyl-7-propylxanthin (OHPPT) from PPT. In this paper, we present the results of stereoselective reduction of PPT into OHPPT when catalysed by whole cells of baker's and a few strains of wine yeast in water and organic solvents.
Publisher

Journal
Year
Issue
2
Pages
174-180
Physical description
Contributors
author
author
author
References
Document Type
ARTICLE
Publication order reference
Elzbieta Pekala, Department of Technology and Biotechnology of Drugs,Medical College of Jagiellonian University, ul. Medyczna 9,30-688 Krakow, Poland
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-4bb40bf5-4861-3e51-9ad4-d13361f47c41
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.